Lipid-lowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients-Reference-Cited by-同舟云学术

Lipid-lowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients

Published:2002-02 Issue:2 Volume:160 Page:369-376
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Inoue Teruo,Hayashi Masatoshi,Takayanagi Kan,Morooka Shigenori

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference41 articles.

1. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity;Steinberg;N Engl J Med,1989

2. Lipoprotein metabolism in the macrophage: implication for cholesterol deposition in atherosclerosis;Brown;Annu Rev Biochem,1983

3. The pathogenesis of atherosclerosis: a perspective for the 1990's;Ross;Nature,1993

4. Coronary atherosclerosis: a maltifactorial disease;Badimon;Circulation,1993

5. Role of oxidized low density lipoprotein in atherogenesis;Witzum;J Clin Invest,1991

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Aqueous Extract of <i>Boscia senegalensis</i> on Hyperglycemia, Hyperlipidemia and Oxidative Stress Induced in Rats;Journal of Diabetes Mellitus;2024

2. Platelet Redox Imbalance in Hypercholesterolemia: A Big Problem for a Small Cell;International Journal of Molecular Sciences;2022-09-28

3. Discovery of 4-benzyloxy and 4-(2-phenylethoxy) chalcone fibrate hybrids as novel PPARα agonists with anti-hyperlipidemic and antioxidant activities: Design, synthesis and in vitro/in vivo biological evaluation;Bioorganic Chemistry;2021-10

4. Rhamnus alaternus Plant: Extraction of Bioactive Fractions and Evaluation of Their Pharmacological and Phytochemical Properties;Antioxidants;2021-02-16

5. Investigation of HMG‐CoA reductase inhibitory and antioxidant effects of various hydroxycoumarin derivatives;Archiv der Pharmazie;2020-07-10